Abstract: The present invention relates to a novel pharmaceutical use of bromide, i.e. the treatment of autism spectral disorder (ASD).
Type:
Grant
Filed:
November 28, 2017
Date of Patent:
June 6, 2023
Assignees:
INSERM, INTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, INRA, INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE, CNRS, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE DE STRASBOURG
Inventors:
Sébastien Roux, Thierry Plouvier, Julie Le Merrer, Jérôme Becker
Abstract: A process for simplified production of a reference milling for determining the milling quality of wheat, includes: a first crushing of a wheat sample; a first sieving of the crushed product into three distinct levels of particle size; a second crushing of oversize particles resulting from the first crushing; a second sieving of the oversize particles thus crushed; a mixing of coarse semolina resulting from the sievings; a third crushing of the mixture of the coarse semolina; a third sieving of the mixture of the coarse semolina thus crushed into two distinct levels of particle size; a mixing of fine semolina resulting from each of the three sievings; a fourth crushing of the mixture of fine semolina; a fourth sieving of the mixture of the fine semolina thus crushed into a single level of particle size; a mixing of the flours resulting from sievings, the mixture constituting the desired milling.
Type:
Grant
Filed:
November 19, 2010
Date of Patent:
June 30, 2015
Assignees:
CHOPIN TECHNOLOGIES, INRA (INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE), ARVALIS (INSTITUT DU VEGETAL)
Inventors:
Arnaud Dubat, Sonia Geoffroy, Joël Abecassis, Marc Chaurand, Robert Pujol, Christine Bar-L'Helgouac'h
Abstract: The present invention relates to methods and pharmaceutical compositions for treating cancer. More specifically, the invention relates to a polypeptide isolated from Brevibacterium aurantiacum that shows methionine gamma-lyase and homocysteinase activities. The present invention also relates to the use of such a polypeptide for the treatment of cancer.
Type:
Grant
Filed:
June 15, 2012
Date of Patent:
June 9, 2015
Assignees:
Institut National de la Santé et de la Recherche Médicale (INSERM), INRA (Institut National de la Recherche Agronomique), UNIVERSITE PARIS SUD-PARIS XI
Abstract: The present invention relates to methods and pharmaceutical compositions for treating cancer. More specifically, the invention relates to a polypeptide isolated from Brevibacterium aurantiacum that shows methionine gamma-lyase and homocysteinase activities. The present invention also relates to the use of such a polypeptide for the treatment of cancer.
Type:
Application
Filed:
June 15, 2012
Publication date:
May 22, 2014
Applicants:
INSERM (Institut National de la Sante et de la Recherche Medicale), UNIVERSITE PARIS SUD-PARIS XI, INRA (Institut National de la Recherche Agronomique)
Abstract: Use of a non-fermented osmotic laxative as an active agent for preparation of a medicinal product for treating and/or preventing colon and/or rectum cancers. A method of treating or preventing colon or rectum cancer comprising administering to a mammal a therapeutically effective amount of a non-fermented osmotic laxative.
Type:
Grant
Filed:
April 18, 2001
Date of Patent:
September 6, 2005
Assignees:
Inra-Institut National de la Recherche Agronomique, ENVT-Ecole Nationale Veterinaire de Toulouse